U. Shance (2003) The cardiopulmonary effects of severe blood loss in anesthetized horses. Vet. Anaesth. Analg. 30(2): 80-86.Wilson DV, Rondenay Y, Shance PU. The cardiopulmonary effects of severe blood loss in anesthetized horses. Vet Anaesth Analg. 2003;30:81-7....
Blood loss during total hip arthroplasty and the relation of different anesthetic techniques to surgical bleeding was explored in a consecutive, prospective study involving 157 patients with no previous history of hip surgery. Intraopera... B Rosberg,H Fredin,C Gustafson - 《Acta Anaesthesiologica Sc...
Postmarketing reports:Agranulocytosis,hemolytic anemia,lymphadenopathynot associated with hypersensitivity disorder[Ref] Hepatic Common(1% to 10%): Lymphadenopathy Uncommon(0.1% to 1%): Liver function tests abnormal, aspartate transaminase (AST) increased ...
Common(1% to 10%): Diarrhea/loose stools, nausea/vomiting, abdominal pain, nausea Uncommon(0.1% to 1%): Abdominal cramps, flatulence, indigestion, mouth ulcers, swollen tongue, dyspepsia, gastrointestinal (GI) infection, ptyalism/excess salivation, GI disturbance, vomiting ...
REFERENCE: New medication to treat shock caused by blood or fluid loss found safe and effective [News Release] November 9, 2020; Dallas, TX. Accessed November 10, 2020.
odds ratio, 0.65; 95% CI, 0.53 to 0.79; P = 1.06 × 10−5 1775 COVID19 cases compared to 3,694 controls patients of Chinese population 32558485 Blood Group O was at lower risk of COVID-19 infection : 21.92% vs. 30.19%, P = 0.018 835 patients and 1255 control participants from ...
renal failure, liver disease, peptic ulcer, acquired immune deficiency syndrome, lymphoma, metastatic cancer, solid tumor, rheumatoid arthritis, coagulopathy, obesity, weight loss, fluid and electrolyte disorders, blood loss anemia, deficiency anemia, alcohol abuse, drug abuse, psychoses, and depression...
(SCOOP cohort) and 4,057 control exomes from the INTERVAL cohort of UK blood donors. SCOOP comprises UK patients with severe obesity (BMI more than 3 s.d. above the mean for age and sex) of early onset (<10 years) recruited to the GOOS. Exome sequencing in a subset of people of ...
Maternal SICd 0/21 (0.0 %) 2/43 (4.6 %) 1.00a Maternal CACe NAf 10/32 (31.3 %) – COVID-19 Severity Asymptomatic NA 13/46 (28.3 %) – Mild NA 21/46 (45.7 %) – Moderate NA 8/46 (17.4 %) – Severe NA 2/46 (4.3 %) – Criti...
Tranaxemic acid (TXA) is effective for reducing blood loss and the need for transfusions during surgeries. Clotting time during the postoperative period is shorter and clot strength is greater in patients treated with TXA. It can also prevent the increase in D-dimer levels without affecting syste...